Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Accenture
Medtronic
Argus Health
Teva
Queensland Health

Generated: June 26, 2019

DrugPatentWatch Database Preview

Curium Company Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CURIUM, and what generic and branded alternatives to CURIUM drugs are available?

CURIUM has fourteen approved drugs.



Summary for Curium
US Patents:0
Tradenames:13
Ingredients:13
NDAs:14

Drugs and US Patents for Curium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Curium SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016517-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Curium SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Curium SODIUM CHROMATE CR 51 sodium chromate cr-51 INJECTABLE;INJECTION 016708-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Curium SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 016515-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Curium GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 018058-001 Approved Prior to Jan 1, 1982 BS RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for Curium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 6,123,916 ➤ Try a Free Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,497,744 ➤ Try a Free Trial
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,384,113 ➤ Try a Free Trial
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,776,894 ➤ Try a Free Trial
Curium TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882-001 Jun 15, 1990 5,573,748 ➤ Try a Free Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,432,963 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Fuji
Moodys
Cantor Fitzgerald
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.